ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $13,449,000 | +5.7% | 383,696 | +9.0% | 0.31% | -6.1% |
| Q1 2021 | $12,722,000 | +28.9% | 352,014 | +3.6% | 0.33% | +3.5% |
| Q4 2020 | $9,869,000 | +8.7% | 339,852 | +5.6% | 0.32% | -21.9% |
| Q3 2020 | $9,083,000 | +0.5% | 321,975 | +15.3% | 0.41% | -13.8% |
| Q2 2020 | $9,035,000 | -22.0% | 279,366 | -1.8% | 0.47% | -37.5% |
| Q1 2020 | $11,588,000 | -33.9% | 284,437 | +0.0% | 0.75% | +0.5% |
| Q4 2019 | $17,535,000 | -13.9% | 284,334 | +1.8% | 0.75% | -20.6% |
| Q3 2019 | $20,360,000 | -11.5% | 279,360 | -0.2% | 0.94% | -11.8% |
| Q2 2019 | $23,014,000 | +17.8% | 279,979 | +1.1% | 1.07% | +13.0% |
| Q1 2019 | $19,531,000 | +109.3% | 276,879 | +33.6% | 0.95% | +77.1% |
| Q4 2018 | $9,333,000 | +593.9% | 207,300 | +771.6% | 0.54% | +764.5% |
| Q3 2018 | $1,345,000 | -66.0% | 23,785 | -61.3% | 0.06% | -68.4% |
| Q4 2017 | $3,958,000 | +22.8% | 61,412 | 0.0% | 0.20% | +18.8% |
| Q3 2017 | $3,224,000 | – | 61,412 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |